TTrialPathMatch Me to Trials
← Back to trials
RecruitingSymptoms of Anxiety

Transcranial Photobiomodulation in Anxiety Disorders

Eligible age

18–100 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.

Sponsor: Francisco Gonzalez-Lima, PhD

You may qualify if…

  • ✓ 18 years of age and older
  • ✓ State-Trait Anxiety Index (STAI) questionnaire score between 40-59 (indicates moderate sub-clinical anxiety)
  • ✓ Patient Health Questionnaire (PHQ-9) score between 1-9 (indicates minimal to mild sub-clinical depression)

You may not qualify if…

  • ✕ STAI score less than 40 or greater than 59
  • ✕ PHQ-9 score greater than 9
  • ✕ Medication instability (i.e., medication change within 6 weeks)
  • ✕ Indicated suicidal ideation
  • ✕ Currently receiving tPBM treatment
  • ✕ Current pregnancy

Where it's recruiting

Texas

Austin

Source: ClinicalTrials.gov · NCT07133893 · last updated 2026-05-14

Transcranial Photobiomodulation in Anxiety Disorders · TrialPath